BioCryst Pharmaceuticals (NASDAQ:BCRX) was downgraded by investment analysts at Merrill Lynch to an “underperform” rating in a note issued to investors on Tuesday, Stock Ratings Network reports. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock opened at $9.37 in last session, and closed at $10.04, while the day range of stock is $9.32 – $10.24. The stock showed a negative weekly performance of -13.75%.
Synthetic Biologics Inc. (NYSEMKT: SYN) saw a big move last session, as the company’s shares fell by over 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. Synthetic Biologics Inc (NYSEMKT: SYN) stock opened at $1.69, in last session and closed at $1.74, by gaining 1.75%. The 52 week range of the stock is $0.95 – $2.10. Company’s market capitalization is $100.92 million.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) rose 10.57%, seemingly on upbeat tone struck at the 32nd Annual J.P. Morgan Healthcare Conference. Amicus Therapeutics, Inc. (NASDAQ:FOLD) stock advanced 3.97% and finished the last session at $2.88. The EPS of the stock remained -1.16. Company’s market capitalization is $142.94 million.
Regulus Therapeutics (NASDAQ:RGLS) Insider Neil Gibson sold 4,421 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, January 21st. Regulus Therapeutics Inc (NASDAQ:RGLS) stock opened the session at $7.85, and closed the session at $8.89. The 52 week range of the stock remained $4.70 – $12.89 and the day range was $7.85 – $8.95.
Leave a Reply